SavedAdd your journal

Journals / Çukurova Anestezi ve Cerrahi Bilimler Dergisi / 2026 / Cilt: 9 Sayı: 2

Psychiatric Burden in Adult Patients with Common Variable Immunodeficiency: A Single-Center Cross-Sectional Study

Yaygın Değişken İmmün Yetmezliği Olan Erişkin Hastalarda Psikiyatrik Yük: Tek Merkezli Kesitsel Bir Çalışma

Özge Argin(SÜREYYAPAŞA GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ EĞİTİM VE ARAŞTIRMA HASTANESİ)0000-0001-7068-2842
Zeynep Yegin Katran(SÜREYYAPAŞA GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ EĞİTİM VE ARAŞTIRMA HASTANESİ)0000-0002-6858-6824
Galip Muzaffer Kürşat Küçükali(ERENKÖY RUH VE SİNİR HASTALIKLARI EĞİTİM VE ARAŞTIRMA HASTANESİ)0009-0009-7612-5954
İsmet Bulut(SÜREYYAPAŞA GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ EĞİTİM VE ARAŞTIRMA HASTANESİ)0000-0002-8111-6149
Pages
421–426
Publication Date
2026-06-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Keywords: Common Variable Immunodeficiency; Primary Immunodeficiency; Anxiety; Depression; Immunoglobulin Replacement Therapy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ABSTRACT Aim: Common Variable Immunodeficiency (CVID) is characterized by recurrent infections and chronic complications.
📊
Key Findings & Data:Psychiatric diagnoses were classified according to DSM-5 criteria.
💡
Conclusion & Impact:Keywords: Common Variable Immunodeficiency; Primary Immunodeficiency; Anxiety; Depression; Immunoglobulin Replacement Therapy
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Yaygın Değişken İmmün Yetmezlik · Primer İmmün Yetmezlik · Anksiyete

Abstract

ABSTRACT Aim: Common Variable Immunodeficiency (CVID) is characterized by recurrent infections and chronic complications. While the infectious burden of CVID has been extensively studied, psychiatric comorbidities remain underrecognized. This study aimed to evaluate psychiatric symptom burden and associated factors in adult CVID patients receiving immunoglobulin replacement therapy. Methods: Sixteen adult patients with CVID were included in this cross-sectional study. Demographic and clinical data were collected retrospectively. Anxiety and depressive symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS). Psychiatric diagnoses were classified according to DSM-5 criteria. Infection frequency before and after immunoglobulin replacement therapy was compared using the Wilcoxon signed-rank test. Associations between clinical variables and HADS scores were analyzed using nonparametric tests. Results: The mean age of the patients was 43.2 ± 14.9 years, and 50% were female. Immunoglobulin replacement therapy was associated with significant reductions in annual pneumonia (p=0.001), sinusitis (p=0.003), and antibiotic use (p=0.001). Clinically significant anxiety (HADS-A ≥11) was observed in 50% of patients, and depressive symptoms (HADS-D ≥11) in 56.3%. Eight patients (50%) met DSM-5 criteria for at least one psychiatric disorder. Anxiety and depressive scores were strongly correlated (ρ=0.939, p<0.001). Social support was significantly associated with both anxiety (p=0.014) and depressive symptoms (p=0.049), whereas diagnostic delay and immunoglobulin replacement therapy delay were not. Conclusion: Despite effective control of infectious complications with immunoglobulin replacement therapy, psychiatric symptom burden remains high in adult CVID patients. Perceived social support appears to be an important determinant of psychological well-being in this population. Keywords: Common Variable Immunodeficiency; Primary Immunodeficiency; Anxiety; Depression; Immunoglobulin Replacement Therapy

Özet

ÖZET Amaç: Common Variable Immunodeficiency (CVID), tekrarlayan enfeksiyonlar ve kronik komplikasyonlarla karakterize bir primer immün yetmezliktir. CVID’de enfeksiyon yükü ayrıntılı olarak incelenmiş olmasına rağmen psikiyatrik eş tanılar yeterince değerlendirilmemiştir. Bu çalışmada, immünoglobulin replasman tedavisi alan erişkin CVID hastalarında psikiyatrik semptom yükü ve ilişkili faktörlerin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Çalışmaya 16 erişkin CVID hastası dahil edildi. Demografik ve klinik veriler retrospektif olarak toplandı. Anksiyete ve depresif semptomlar Hastane Anksiyete ve Depresyon Ölçeği (HADS) ile değerlendirildi. Psikiyatrik tanılar DSM-5 kriterlerine göre sınıflandırıldı. İmmünoglobulin replasman tedavisi öncesi ve sonrası enfeksiyon sıklığı Wilcoxon işaretli sıralar testi ile karşılaştırıldı. HADS skorları ile klinik değişkenler arasındaki ilişkiler nonparametrik testlerle analiz edildi. Bulgular: Hastaların yaş ortalaması 43.2 ± 14.9 yıl olup, %50’si kadındı. İmmünoglobulin replasman tedavisi sonrası yıllık pnömoni (p=0.001), sinüzit (p=0.003) ve antibiyotik kullanımında (p=0.001) anlamlı azalma saptandı. Klinik olarak anlamlı anksiyete (HADS-A ≥11) hastaların %50’sinde, depresif semptomlar (HADS-D ≥11) ise %56.3’ünde görüldü. Hastaların %50’si DSM-5’e göre en az bir psikiyatrik tanı almaktaydı. Anksiyete ve depresyon skorları arasında güçlü bir korelasyon bulundu (ρ=0.939, p<0.001). Sosyal destek varlığı hem anksiyete (p=0.014) hem de depresyon skorları (p=0.049) ile anlamlı ilişkili bulundu; tanı gecikmesi ve immünoglobulin replasman tedavisi gecikmesi ile anlamlı ilişki saptanmadı. Sonuç: İmmünoglobulin replasman tedavisi enfeksiyon sıklığını belirgin şekilde azaltmasına rağmen, erişkin CVID hastalarında psikiyatrik semptom yükü yüksek düzeyde seyretmektedir. Algılanan sosyal destek, psikolojik iyilik halinin önemli belirleyicilerinden biri olabilir. Anahtar Kelimeler: Yaygın Değişken İmmün Yetmezlik; Primer İmmün Yetmezlikler; Anksiyete; Depresyon; İmmünoglobulin Replasman Tedavisi

🔖

Cite This Article

Argin, Ö., Katran, Z. Y., Küçükali, G. M. K., Bulut, İ. (2026). Psychiatric Burden in Adult Patients with Common Variable Immunodeficiency: A Single-Center Cross-Sectional Study. Çukurova Anestezi ve Cerrahi Bilimler Dergisi, Cilt: 9 Sayı: 2, 421–426. https://doi.org/10.36516/jocass.1907239

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473-1507. doi:10.1007/s10875-022-01289-3.
  2. Seminario G, Gonzalez-Serrano ME, Aranda CS, Grumach AS, Segundo GRS, Regairaz L, et al. The Latin American Society for Immunodeficiencies Registry. J Clin Immunol. 2024;45(1):28. doi:10.1007/s10875-024-01822-6.
  3. Elsink K, van Montfrans JM, van Gijn ME, Blom M, van Hagen PM, Kuijpers TW, et al. Cost and impact of early diagnosis in primary immunodeficiency disease: a literature review. Clin Immunol. 2020;213:108359. doi:10.1016/j.clim.2020.108359.
  4. Ryan P, Redenbaugh V, McGucken J, Kindle G, Devlin LA, Coulter T, et al. Inborn errors of immunity on the Island of Ireland: a cross-jurisdictional UKPID/ESID Registry report. J Clin Immunol. 2022;42(6):1293-1299. doi:10.1007/s10875-022-01274-w.
  5. Mellouli F, Mustapha IB, Khaled MB, et al. Report of the Tunisian Registry of Primary Immunodeficiencies: 25 years of experience (1988-2012). J Clin Immunol. 2015;35(8):745-753. doi:10.1007/s10875-015-0206-9.
  6. Peshko D, Kulbachinskaya E, Korsunskiy I, Kondrikova E, Pulvirenti F, Quinti I, et al. Health-related quality of life in children and adults with primary immunodeficiencies: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019;7(6):1929-1957.e5. doi:10.1016/j.jaip.2019.02.013.
  7. Ahmed Meelad R, Abd Hamid IJ, Zainudeen ZT, et al. Health-related quality of life of patients and families with primary immunodeficiency in Malaysia: a cross-sectional study. J Clin Immunol. 2023;43(5):999-1006. doi:10.1007/s10875-023-01463-1.
  8. Kuburovic NB, Pasic S, Susic G, Stevanovic D, Kuburovic V, Zdravkovic S, et al. Health-related quality of life, anxiety, and depressive symptoms in children with primary immunodeficiencies. Patient Prefer Adherence. 2014;8:323-330. doi:10.2147/PPA.S58040.
  9. Ridao-Manonellas S, Fábregas-Bofill A, Núñez-Rueda G, et al. Health-related quality of life and multidimensional fatigue scale in children with primary immunodeficiencies. J Clin Immunol. 2020;40(4):602-609. doi:10.1007/s10875-020-00775-w.
  10. Urschel S, Kayikci L, Wintergerst U, Notheis G, Jansson A, Belohradsky BH. Common variable immunodeficiency disorders in children: delayed diagnosis despite typical clinical presentation. J Pediatr. 2009;154(6):888-894. doi:10.1016/j.jpeds.2008.12.020.
  11. Wilmott RW. Delayed diagnosis in common variable immunodeficiency. J Pediatr. 2009;154(6):A1. doi:10.1016/j.jpeds.2009.04.019.
  12. Baloh C, Reddy A, Henson M, Prince K, Buckley R, Lugar P. 30-year review of pediatric- and adult-onset CVID: clinical correlates and prognostic indicators. J Clin Immunol. 2019;39(7):678-687. doi:10.1007/s10875-019-00674-9.
  13. Bargir UA, Setia P, Desai M, et al. Common variable immunodeficiency disorder: a decade of insights from a cohort of 150 patients in India and the use of machine learning algorithms to predict severity. J Clin Immunol. 2025;45(1):127. doi:10.1007/s10875-025-01897-9.
  14. Moodley S, Goddard E, Levin M, et al. A retrospective description of primary immunodeficiency diseases at Red Cross War Memorial Children's Hospital, Cape Town, South Africa, 1975-2017. S Afr Med J. 2020;110(3):197-203. doi:10.7196/SAMJ.2020.v110i3.14200.
  15. Routes J, Costa-Carvalho BT, Grimbacher B, et al. Health-related quality of life and health resource utilization in patients with primary immunodeficiency disease prior to and following 12 months of immunoglobulin G treatment. J Clin Immunol. 2016;36(5):450-461. doi:10.1007/s10875-016-0279-0.
  16. Rider NL, Kutac C, Hajjar J, et al. Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment. J Clin Immunol. 2017;37(5):461-475. doi:10.1007/s10875-017-0404-8.
  17. Heath J, Lehman E, Saunders EF, Craig T. Anxiety and depression in adults with primary immunodeficiency: how much do these patients experience and how much do they attribute to their primary immunodeficiency? Allergy Asthma Proc. 2016;37(5):409-415. doi:10.2500/aap.2016.37.3977.
  18. Xiao N, Huang X, Zang W, Kiselev S, Bolkov MA, Tuzankina IA, et al. Health-related quality of life in patients with inborn errors of immunity: a bibliometric analysis. Front Immunol. 2024;15:1371124. doi:10.3389/fimmu.2024.1371124.
  19. Xiao N, Huang X, Yang D, Zang W, Kiselev S, Bolkov MA, et al. Health-related quality of life in patients with inborn errors of immunity: a systematic review and meta-analysis. Prev Med. 2024;186:108079. doi:10.1016/j.ypmed.2024.108079.